Received Jan 19, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
The nerve endings under the skin are still firing off; rash; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of nerve pain in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced nerve pain (Verbatim: The nerve endings under the skin are still firing off) and rash (Verbatim: rash). The outcome of the nerve pain was not resolved and the outcome of the rash was resolved. It was unknown if the reporter considered the nerve pain and rash to be related to Shingrix. It was unknown if the company considered the nerve pain and rash to be related to Shingrix. Additional Information: GSK Receipt Date: 15-JAN-2026 This case was reported by a patient via interactive digital media. The reporter stated that the patient had still been suffering after 19 months, her nerve endings under the skin had still been firing long after the rash had gone. The batch number was not provided, and we are unable to contact the reporter.